Last reviewed · How we verify
Silver Nanoparticles in gel form
At a glance
| Generic name | Silver Nanoparticles in gel form |
|---|---|
| Sponsor | Cairo University |
| Modality | Small molecule |
| Phase | FDA-approved |
Approved indications
Common side effects
Key clinical trials
- Antimicrobial Efficacy of Nano-Based ICM on E.F (NA)
- Assessment of Postoperative Pain After Using Various Intracanal Medication in Patients With Necrotic Pulp (PHASE4)
- Topical Application of Silver Nanoparticles and Oral Pathogens in Ill Patients (NA)
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- Silver Nanoparticles in gel form CI brief — competitive landscape report
- Silver Nanoparticles in gel form updates RSS · CI watch RSS
- Cairo University portfolio CI